Biochemistry & Molecular Biology

Dr. Boothman is currently working as Professor of Biochemistry at Indiana University. Dr Scientist received his Doctoral degree or PhD in Microbiology and Immunology from the University of Miami. He then worked at the Dana Farber Cancer Institute under Dr. Arthur B. Pardee as a post-doctoral felllow, served as Assistant Professor at the University of Michigan and then Associate Professor at the University of Wisconsin-Madison. Dr. Boothman was then Professor and Associate Director of Basic Science at the Case Western reserve Univeristy and Professor of Pharmacology and Associate Director for Translational Research at UT Southwestern Medical Center. Dr. Boothman is currently Professor of Biochemistry and Molecular Biology and Associate Director for Translational Research at Indiana University and has authored over 175 peer-review publications in various journals and books. His publications reflect his research interests in experimental therapeutics, radiation oncology, and molecular biology. Dr. Boothman is serving as President of the Society for Experimental Biology and Medicine and has four NIH/NCI R01s and one U01 in cancer biology.

Cell stress responses; NQO1; PARP hyperactivation; programmed necrosis; radiation bioactivatable therapy

2002-2006. Head of the grant project in the frame of the State Program “Cooperation of Science and Education”. 2007-2009. Head of the 2 grant projects by Russian Foundation for Basic Research. 2009-2011. Head of the grant project funded by Russia Academy of Science Board. 2011-current. Head of 5 grant projects by Russian Foundation for Basic Research. Chairman of RUS-BOL and member of Central council in Vavilov’s Genetic Society of Russia.

Population, Evolutionary & Ecological Genetics, Evolutionary Genomics, Conservation Genetics, Phylogenetics, Genetic Basis of Heterosis, Genetics of Quantitative Traits, Genetics of Reproduction and Animal Stock Rehabilitation.

Miguel Mantilla has completed his MSc in Molecular Biology from the University of Buenos Aires and his PhD at the age of 30 years from the Hebrew University of Jerusalem. He is the Scientific Director of Quimiolab (Colombia), a premier Biotech company that provides assistance for several medical centres and research facilities in Latin America that are seeking for advice and technological renewal in order to provide more accurate services so they can impact positively in patient Healthcare. He has worked in 7 countries with their most important Clinical Research professionals and is an international consultant.

clinical algorithms, infectious diseases, molecular diagnostics, qPCR

Segundo Mesa Castillo. As Specialist in Neurology, he worked for 10 years in the Institute of Neurology of Havana, Cuba. He has worked in Electron Microscopic Studies on Schizophrenia for 32 years. He was awarded with the International Price of the Stanley Foundation Award Program and for the Professional Committee to work as a fellowship position in the Laboratory of the Central Nervous System Studies, National Institute of Neurological Diseases and Stroke under Dr. Joseph Gibbs for a period of 6 months, National Institute of Health, Bethesda, Maryland, Washington D.C. USA, June 5, 1990. At present he is member of the Scientific Board of the Psychiatric Hospital of Havana and give lectures to residents in psychiatry.

Psychiatry, Biochemistry

Dr. Krishna Dronamraju received his Ph.D. in human genetics under the direction of J.B.S. Haldane. He continued research in human genetics, biometry, biotechnology, history of science and scientific biography, publishing 18 books and over 200 research papers and articles. His research on cleft lip and palate led to the discovery of a positive correlation between the frequency of fetal deaths and increasing liability to cleft formation. In the study of infectious disease, he followed the tradition initiated by his mentor J.B.S. Haldane, searching for relationships between infectious diseases and various genetic anomalies. Dr. Dronamraju organized and chaired several international conferences in population genetics, infectious diseases, biotechnology and the history of science in several countries. He is the President of Foundation for Genetic Research in Houston, USA and a Visiting Professor of the University of Paris, and an Honorary Research Fellow of the University of London. His latest book is: “Haldane, Mayr and Beanbag Genetics”, Oxford University Press, 2011. He has been nominated for the Nobel Prize.

Genetic Research